Connect with us

Business

Covid-19: FDA allows emergency use of antibody drug Regeneron – BBC News

Regeneron says its antibody treatment is effective when used early after a Covid-19 diagnosis.

Published

on

post featured image
ADVERTISEMENT

media captionThe BBC’s Rebecca Morelle explains how the monoclonal antibodies work
US officials have granted emergency authorisation for an experimental antibody treatment given to President Trump after his Covid-19 diagnosis.
The drug, developed by Regeneron, will be allowed for use in people who have tested positive for the virus and are at risk of severe illness.
Studies suggest the therapy is effective when administered early after diagnosis, the company says.
It comes as Covid-19 cases in the…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
New York’s 29 Micro-Cluster Zones Bring Statewide Positivity Near 4% – NBC New York
post featured image
If a stimulus package doesn’t pass soon, here’s what Biden could do – CNET
post featured image
Top consulting firm McKinsey suggested Purdue Pharma give pharmacies rebates for OxyContin overdoses | TheHill – The Hill